{"title":"膀胱癌学会2018精选摘要。","authors":"Nermarie Velázquez","doi":"10.3909/riu02001BCA","DOIUrl":null,"url":null,"abstract":"sensitivity of 67%, specificity of 75%, and similar issues with FP results due to hematuria, stones, infection, and recent instrumentation. 2 UroVysion ® FISH detects alteration in chromosomes 3,7,17 and loss of 9p21 locus. As this test is based on cytology, it requires trained personnel and special equipment. It does not come as a POC and has better outcomes for high-grade tumors and can detect occult carcinoma in situ (CIS). 3 ImmunoCyt ™ looks at three monoclonal antibodies associated with urothelial carcinoma","PeriodicalId":21185,"journal":{"name":"Reviews in urology","volume":"20 1","pages":"31-37"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3909/riu02001BCA","citationCount":"3","resultStr":"{\"title\":\"Bladder Cancer Academy 2018 Selected Summaries.\",\"authors\":\"Nermarie Velázquez\",\"doi\":\"10.3909/riu02001BCA\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"sensitivity of 67%, specificity of 75%, and similar issues with FP results due to hematuria, stones, infection, and recent instrumentation. 2 UroVysion ® FISH detects alteration in chromosomes 3,7,17 and loss of 9p21 locus. As this test is based on cytology, it requires trained personnel and special equipment. It does not come as a POC and has better outcomes for high-grade tumors and can detect occult carcinoma in situ (CIS). 3 ImmunoCyt ™ looks at three monoclonal antibodies associated with urothelial carcinoma\",\"PeriodicalId\":21185,\"journal\":{\"name\":\"Reviews in urology\",\"volume\":\"20 1\",\"pages\":\"31-37\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.3909/riu02001BCA\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reviews in urology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3909/riu02001BCA\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews in urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3909/riu02001BCA","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
sensitivity of 67%, specificity of 75%, and similar issues with FP results due to hematuria, stones, infection, and recent instrumentation. 2 UroVysion ® FISH detects alteration in chromosomes 3,7,17 and loss of 9p21 locus. As this test is based on cytology, it requires trained personnel and special equipment. It does not come as a POC and has better outcomes for high-grade tumors and can detect occult carcinoma in situ (CIS). 3 ImmunoCyt ™ looks at three monoclonal antibodies associated with urothelial carcinoma
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
